VAXX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 59.07%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $51,877.67

Vaxxinity Insider Trading History Chart

Vaxxinity Share Price & Price History

^$0.12

▼ -0.01 (-7.61%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

A new way to collect income from stocks

From DTI | Ad

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

Vaxxinity Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/8/2023	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	25,089	$1.67	$41,898.63	8,713,663
9/6/2023	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	5,308	$1.88	$9,979.04	8,759,064
1/23/2023	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	405,217	$3.35	$1,357,476.95	8,764,372
12/1/2022	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	270,964	$2.97	$804,763.08	9,180,710
9/6/2022	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	25,243	$2.40	$60,583.20	9,451,674
8/25/2022	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	22,757	$2.33	$53,023.81	9,476,917
8/23/2022	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	33,785	$2.45	$82,773.25	9,583,460
6/16/2022	Lou Reese	Chairman	Buy	100,000	$1.99	$199,000.00	51,737,344
6/13/2022	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	92,569	$2.43	$224,942.67	9,617,245
6/10/2022	Movers Lab Fund I Lp Prime	Major Shareholder	Sell	28,378	$2.80	$79,458.40	9,709,814
6/9/2022	Mei Mei Hu	Insider	Buy	10,978	$2.72	$29,860.16	51,637,344
6/8/2022	United Biomedical Inc	Major Shareholder	Buy	10,000	$2.95	$29,500.00	51,626,366
4/27/2022	Lou Reese	Chairman	Buy	4,807	$3.58	$17,209.06	51,616,366
4/26/2022	United Biomedical Inc	Major Shareholder	Buy	18,105	$3.45	$62,462.25	51,611,559
4/25/2022	Mei Mei Hu	Insider	Buy	8,038	$3.37	$27,088.06	51,593,454

The Hard Truth About Investing For Retirement

From Insiders Exposed | Ad

Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.

Click To Access This Powerful Training Right Now!

SEC Filings (Institutional Ownership Changes) for Vaxxinity (NASDAQ:VAXX)

82.95% of Vaxxinity stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vaxxinity Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/7/2024	Ieq Capital LLC	83,262	$71K	0.0%	N/A	0.066%
11/7/2023	New York State Common Retirement Fund	23,642	$32K	0.0%	-46.4%	0.019%
10/31/2023	McAdam LLC	68,281	$94K	0.0%	+47.4%	0.054%
10/24/2023	Bank of New York Mellon Corp	121,522	$0.17M	0.0%	-14.8%	0.096%
10/19/2023	Clarius Group LLC	20,000	$27K	0.0%	N/A	0.016%
8/4/2023	American International Group Inc.	20,514	$52K	0.0%	N/A	0.016%
7/25/2023	Raymond James Financial Services Advisors Inc.	17,001	$43K	0.0%	+69.7%	0.013%
5/3/2023	Integrated Wealth Concepts LLC	11,000	$25K	0.0%	N/A	0.009%
5/2/2023	Lincoln National Corp	41,070	$93K	0.0%	N/A	0.033%
5/1/2023	Virtu Financial LLC	12,263	$28K	0.0%	-31.3%	0.010%
4/24/2023	McAdam LLC	46,324	$0.11M	0.0%	N/A	0.037%
4/21/2023	Blue Zone Wealth Advisors LLC	27,500	$62K	0.0%	N/A	0.022%
4/18/2023	ETF Managers Group LLC	43,836	$100K	0.0%	+39.5%	0.035%
3/23/2023	ETF Managers Group LLC	31,427	$44K	0.0%	-15.5%	0.025%
11/15/2022	Prime Movers Lab LLC	17,603,276	$31.37M	22.6%	-1.4%	13.968%
11/4/2022	First Republic Investment Management Inc.	199,022	$0.39M	0.0%	N/A	0.158%
8/10/2022	Clarius Group LLC	20,000	$31K	0.0%	N/A	0.016%
7/22/2022	Truist Financial Corp	20,738	$33K	0.0%	N/A	0.016%
7/21/2022	Hollencrest Capital Management	20,000	$31K	0.0%	N/A	0.016%
3/10/2022	Prime Movers Lab LLC	18,027,314	$91.02M	17.4%	N/A	14.377%
2/15/2022	Adage Capital Partners GP L.L.C.	1,001,670	$5.62M	0.0%	N/A	0.799%
2/14/2022	ETF Managers Group LLC	37,884	$0.21M	0.0%	N/A	0.030%
2/1/2022	FNY Investment Advisers LLC	4,847	$27K	0.0%	N/A	0.004%

Data available starting January 2016

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and VXX-301, an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; VXX-401 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Merritt Island, Florida.

Today's Range

Now: $0.12

$0.12

$0.14

50 Day Range

MA: $0.64

$0.13

$0.86

52 Week Range

Now: $0.12

$0.12

$3.10

Volume

2,931,964 shs

Average Volume

584,188 shs

Market Capitalization

$15.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.39

Who are the company insiders with the largest holdings of Vaxxinity?: Vaxxinity's top insider investors include:
Lou Reese (Chairman)
Mei Mei Hu (Insider)
United Biomedical Inc (Major Shareholder)
Movers Lab Fund I Lp Prime (Major Shareholder)
Learn More about top insider investors at Vaxxinity.